IntoCell Statistics
Total Valuation
IntoCell has a market cap or net worth of KRW 982.91 billion. The enterprise value is 962.69 billion.
| Market Cap | 982.91B |
| Enterprise Value | 962.69B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IntoCell has 14.85 million shares outstanding. The number of shares has increased by 6.06% in one year.
| Current Share Class | 14.85M |
| Shares Outstanding | 14.85M |
| Shares Change (YoY) | +6.06% |
| Shares Change (QoQ) | +5.75% |
| Owned by Insiders (%) | 22.29% |
| Owned by Institutions (%) | 9.56% |
| Float | 11.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 583.85 |
| PB Ratio | 40.82 |
| P/TBV Ratio | 49.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -92.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -133.20 |
Financial Position
The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.42.
| Current Ratio | 8.06 |
| Quick Ratio | 8.03 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.41 |
| Interest Coverage | -40.22 |
Financial Efficiency
Return on equity (ROE) is -62.07% and return on invested capital (ROIC) is -24.47%.
| Return on Equity (ROE) | -62.07% |
| Return on Assets (ROA) | -20.17% |
| Return on Invested Capital (ROIC) | -24.47% |
| Return on Capital Employed (ROCE) | -28.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 51,554.00 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 59.35 |
| Average Volume (20 Days) | 919,156 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IntoCell had revenue of KRW 1.68 billion and -10.45 billion in losses. Loss per share was -755.25.
| Revenue | 1.68B |
| Gross Profit | 1.68B |
| Operating Income | -10.56B |
| Pretax Income | -10.45B |
| Net Income | -10.45B |
| EBITDA | -9.86B |
| EBIT | -10.56B |
| Loss Per Share | -755.25 |
Balance Sheet
The company has 30.44 billion in cash and 10.22 billion in debt, giving a net cash position of 20.22 billion or 1,361.69 per share.
| Cash & Cash Equivalents | 30.44B |
| Total Debt | 10.22B |
| Net Cash | 20.22B |
| Net Cash Per Share | 1,361.69 |
| Equity (Book Value) | 24.08B |
| Book Value Per Share | 1,631.75 |
| Working Capital | 27.50B |
Cash Flow
In the last 12 months, operating cash flow was -7.08 billion and capital expenditures -144.35 million, giving a free cash flow of -7.23 billion.
| Operating Cash Flow | -7.08B |
| Capital Expenditures | -144.35M |
| Free Cash Flow | -7.23B |
| FCF Per Share | -486.76 |
Margins
| Gross Margin | 99.56% |
| Operating Margin | -627.37% |
| Pretax Margin | -620.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IntoCell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.06% |
| Shareholder Yield | -6.06% |
| Earnings Yield | -1.06% |
| FCF Yield | -0.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IntoCell has an Altman Z-Score of 14.31 and a Piotroski F-Score of 3.
| Altman Z-Score | 14.31 |
| Piotroski F-Score | 3 |